팝업레이어 알림

팝업레이어 알림이 없습니다.

Create health, happy lives and beautiful future

EDGC is at the center of the revolution beginning to disappear a border between industries as technologies converge.

  • Help to maintain healthy pregnancy by analyzing fetal chromosomal abnormalities.
  • Detect chromosomal abnormalities a baby may have.
  • Parents can take care of children’s health with proper treatment of analyzing their genes.
  • Analyze the genetic risk of diseases to help prevent them in advance.

Genetic Analysis Service Throughout the Life Cycle

  • What does
    your DNA look like?

    MIT Technology Review paid attention to
    ‘Genetic Fortune Telling’ in ’10 Breakthrough Technologies 2018’.
    Genes have all the information you may wish to know.
    Your genes exactly know your weaknesses, personality, aptitude and even the most effective exercises for you.
    Start to prepare for the era of the healthy 100-year life through genetic analysis.

  • EDGC is
    a global healthcare
    company.

    EDGC analyzes your genes based on
    cutting-edge genetic analysis technology and bioinformatics technology and suggests personalized lifestyle to help prevent diseases.

Business

EDGC Service

  • Non-Invasive Prenatal Test

    NICE®

    NICE® test, which has been verified its accuracy and reliability by acquiring CLIA and CAP certificates, detects fetal chromosomal abnormalities safely and easily.

  • Newborn Genetic Screening Test

    bebegene®

    bebegene® which detects chromosomal abnormalities such as major genetic diseases, Wilson’s Disease, ADHD, hearing loss and so on is the first test for a precious baby.

  • Integrated Genotype and Phenotype Test

    MYGENPLAN®

    MYGENPLAN® is the first integrated test in South Korea which analyzes metabolic genes and biological age and suggests personalized healthcare guide.

  • Cancer and General Disease Prediction Test

    gene2me® Plus

    gene2me® Plus predicts the genetic risk of major cancer, general diseases and eye diseases, and designs healthy future with early personalized treatment.

Recent News

EDGC Recent News

Article

[Management of SolGent and EDGC, including EDGC co-CEO Shin Sang-cheol, third from left in the front row, during a groundbreaking ceremony for Solgent's second production facility in Daejeon, June 10.] By Jung Min-hoSolGent, a subsidiary of Korean genome sequencing company EDGC, has begun building its second COVID-19 detection kit production facility in Daejeon to meet increasing demand overseas.When completed near its first manufacturing plant in September, the new one is expected to be capable of producing kits for 30 million tests a week, the company said Monday.The kits (DiaPlexQ) have been exported to more than 50 countries, including Germany and the United States. It has received CE marking, a certification that demonstrates conformity with health and safety standards for products sold in Europe, and emergency use authorization from the U.S. Food and Drug Administration."The company's first-quarter revenues this year have already reached 95 percent of revenues of the whole of last year," an official told The Korea Times.Last Wednesday, 100 officials of SolGent and EDGC attended the groundbreaking ceremony."Thanks to SolGent's advanced technology and know-how, it could take a major step forward during the pandemic," EDGC co-president Shin Sang-cheol said during the event.In a statement, Seok Do-su and You Jae-hyung, co-CEOs of SolGent, said they would continue to build trust with customers around the world with top-quality products and innovations. 

2020.06.15

Global Network

EONE-DIAGNOMICS GENOME CENTER

EDGC Promotion Video

No posts found.